A variety of different approaches have been employed to enable implantation of electronic medical microdevices. A novel method of producing low-cost, rapidly fabricated implantable enclosures from biocompatible silicone is presented in this paper. This method utilises 3D computer-aided design software to design and model the enclosures prior to fabrication. The enclosures are then fabricated through additive manufacturing from biocompatible silicone using a 3D bioprinter. In this paper, four different implantable enclosure designs are presented. A prototyping stage with three different prototypes is described, these prototype enclosures are then evaluated through submersion and operation tests. A final design is developed in response to the obtained results, and then evaluated in a long term temperature controlled submersion test. The evaluation results are presented and discussed. Several areas of future works are identified and discussed.
Introduction
Deep brain stimulation (DBS) is a technique which has shown significant benefits when used to treat the symptoms of a variety of physical and neurological conditions (Miocinovic et al., 2013) . Pluta et al. (2011) describe DBS as a surgical technique where an electrode is placed in the subcortical brain structures. This electrode is attached to a stimulation device which produces highly precise electrical signals in order to stimulate neurons. This targeted electrical stimulation can have a significant effect on symptoms arising from a variety of physical disorders and is an accepted treatment option for treating Parkinson's disease symptoms in humans (Bronstein et al., 2011) . Currently preclinical research is taking place to investigate the effectiveness of DBS in treating the symptoms of serious neurological conditions including treatment-resistant depression and addiction (Anderson et al., 2012; Luigjes et al., 2012) . In these pre-clinical studies, DBS devices are used with animal models over an extended period of time to study the therapeutic mechanisms of the treatment. Most existing DBS devices are highly sophisticated and require complex circuitry and enclosures which are designed to be placed on a desk or bench, thus performing uninterrupted animal behavioural tests has been difficult. If this device were to be implanted in the animal, it would allow the animal to act in a less restricted manner, which may lead to improved behavioural research results.
The authors have been performing research into developing an effective DBS microdevice for pre-clinical applications (Kouzani et al., 2013; Kouzani et al., 2012) , with one of their latest devices being specifically designed for implantation. The device comprises a number of low-cost low-power components. These components have been mounted onto a miniature two-layer printed circuit board specifically designed for this application. This board measures only 12 mm long, 5.5 mm wide and 1 mm high with the components installed. This board has been designed specifically such that it can be implanted under the skin of an animal model with minimal irritation. However, this device is inherently bioincompatibile due to the heavy metals and live electrical signals present. This means that the device cannot be directly implanted into the animal and must be placed into a biocompatible enclosure in order to be implanted. Biocompatibility is defined by Dorland (2012) as "not having toxic or injurious effects on biological function".
A widely used material is medical grade silicone providing biocompatibility and suitability for sterilisation which is appropriate for use in medical applications. In addition to biocompatibility, medical grade silicone has a high level of elasticity, flexibility, and resilience which has led to silicone being one of the most widely evaluated and utilised biomaterials (Colas and Curtis, 2004) .
A number of methods have been employed to make an electronic device biocompatible and implant friendly. Two key methods to increase the biocompatibility of a device using silicone include: dipping or moulding. In the former (Das et al., 2013) , a silicone coating is deposited and then cured on the device in order to coat the entire surface of the device with biocompatible material. In the latter, a positive mould is produced from metal, glass, or other materials in the inverse design required for the biocompatible enclosure. Silicone is then injected into the mould in order to produce a highly accurate and repeatable enclosure. While the former is low-cost and suitable for low-volume applications, the formation of coating is not highly controllable, and that there is lack of repeatability and consistency. More importantly, it is not possible to produce enclosures of specific shapes required in some implant applications. On the other hand, while the latter is suitable for high-volume production, it is expensive and has a long turnaround time for producing new moulds and thus is not suitable for low-volume applications.
This paper presents a novel approach for the low-cost and rapid design and fabrication of biocompatible silicone enclosures for implantable microdevices. The approach involves design and formation of the 3D model of the enclosure using a 3D computer-aided design (CAD) software tool such as SolidWorks. Next, the generated 3D model is loaded into a 3D bioprinter which is capable of printing in medical grade silicone using pressure controlled extrusion printing. This work is a continuation and extension of an earlier preliminary work (Adams et al., 2015) .
3D bioprinter
The bioprinter selected to produce the enclosures in this research was the EnvisionTEC GmbH Bioplotter which is a rapid prototyping system designed to print using a large variety of materials (EnvisionTEC, 2015) . It allows for a 3D CAD model to be created as a physical object using pressure controlled extrusion. Materials that are suitable for use in this bioprinter range from viscous pastes to liquids, and are extruded from a standard 30cc syringe with a Luer lock tip using pressure from an external nitrogen source. The pressure is applied to the syringe which is moved in three dimensions, this syringe deposits a strand of the print material onto the print bed to produce the object. The size of this strand is controlled by altering the speed of the print-head and the pressure applied to the material in the syringe. Designs are produced in an additive manufacturing manner where the CAD model is sliced into layers of fixed height and then printed one layer at a time with each layer being printed on top of the layer below. The features of the bioprinter include 3-axis positioning system with high movement accuracy, cell printing with up to five types of cells per object, high flexibility in the choice of materials, fast printing speed, a large building volume, and flexible inner structure design. Using this method of fabrication, an enclosure can be rapidly produced with a defined outer form and an open inner structure.
Prototyping
In order to gain a greater understanding of the possible issues facing the production of a 3D printed biocompatible enclosure, a number of prototypes were designed fabricated and tested. This research methodology took advantage of the 3D printing technology available and allowed for a number of different designs to be produced and tested in a short period of time. The enclosures designed and fabricated aimed to enable the 12 mm × 5.5 mm × 1 mm DBS device to be implanted into a murine animal model. In order to successfully implant the DBS device and facilitate effective DBS research, the enclosure must have minimal impact on the animal to allow for as close to normal behaviour as possible while the device is implanted.
CAD models
Three different prototype implantable enclosure designs were developed which are differentiated by the position of the DBS device in the enclosure as well as by the outer profile. All of the 3D models were developed in Solidworks (Dassault Systemes SolidWorks Corporation, Velizy, France), and designed to be 3D printed without the need for a support material. Support material was avoided in order to limit the amount of post-processing required.
The first design is shown in Figure 1 (a) and is a two-piece rectangular design where each piece is 14 mm × 10 mm × 3.5 mm with sides 90° to the base. When both sections are joined, this design has an inner cavity of dimensions 11 mm × 7 mm × 2 mm to house the DBS device. The key objective of this enclosure design was to develop the simplest to manufacture enclosure possible using the 3D printing process, thus the design has vertical sides and a rectangular profile. The top and bottom sections of this enclosure are identical in design, and the DBS device is positioned between them to physically isolate it from the surrounding tissue and body fluids. In order to seal the two pieces of this design, medical-grade silicone is used to bond the top and bottom sections isolating the DBS device from the tissue surrounding the implant. The second prototype design as shown in Figure 1 (b) is an altered version of the first design where a rounded outer contour of radius 4 mm is used to eliminate the 90° edges. The key objective of this enclosure design is to make a more implant friendly version of the first design with less sharp edges. The flat side of this enclosure is kept from the first design to maintain the manufacturing process simple. The DBS device is positioned within the enclosure similarly to the first design and the enclosure is sealed in the same manner.
The third prototype design as shown in Figure 1 (c) is a 14 mm tall cylinder with a base diameter of 8 mm, the inner cavity in this design is 13 mm × 7 mm × 3 mm. The aim of this design is to create a functional enclosure out of a single printed piece, not requiring a lid. This reduces the number of surfaces to be sealed after fabrication and aims to provide better isolation from the tissue surrounding the implant. The DBS device is placed into the inner cavity which is then sealed using medical-grade silicone. 
Fabrication
All of the models were printed in silicone on an EnvisionTEC GmbH Bioplotter (EnvisionTEC, Gladbeck, Germany) shown in Figure 2 . The bioplotter was chosen to produce these designs over a more traditional 3D printer due to the ability to accurately print using biocompatible silicone. By keeping the silicone at a constant 20C and using a syringe as the extrusion system, the material deposit during the print was consistent and predictable. The operating parameters of the Bioplotter were determined through the manufacturer's testing procedure (EnvisionTEC, 2015) . Table 1 shows the determined operating parameters for printing the silicone. This mix of material volume and deposit speed meant that the designs could be produced rapidly (under 5 minutes per design) while still allowing for a high level of bonding between the layers.
In order to fabricate the enclosures, the following procedure was used:
1 Load the 3D Model STL file into the Bioplotter RP software.
2 Select the appropriate build area and material (100 mm × 100 mm, and 250 µm silicone).
3 Reposition the model into a location where it can be printed.
4 Slice the model into layers of the appropriate thickness (250 µm).
5 Export to the Visual Machine plotting software.
6 Turn on the Bioplotter.
7 Assign the appropriate material (250 µm silicone) to the part.
8 Assign the appropriate internal pattern to the part.
9 Save the part.
10 Insert the material cartridge and the needle tip into the printing head.
11 Assign the appropriate material and needle tip to the print head in the Visual Machine software.
12 Calibrate the print head.
13 Purge and clean the print head.
14 Begin the print.
15 When the print is complete cure the parts at room temperature (approximately 21°C) for 4-6 hours. Through following this procedure, the three prototype enclosures were all successfully printed. These were produced in such a manner that it should be relatively simple to reproduce these enclosures. Figure 3 shows samples of the three printed enclosures, together with the circuit board of the DBS device.
Testing
In order to assess the suitability of the 3D printed prototype enclosures for implantation, two tests were conducted: a submersion test and an operation test.
Figure 3
The three printed prototype enclosures
Submersion test
The submersion test was performed on both of the two piece enclosures of Design 1 and Design 2 to gauge if they were waterproof when submerged for an extended period of time. A piece of copy paper was placed into the each device cavity in order to observe if the enclosure leaked during the submersion test (see Figure 4a ). Silicone was then used to attach the pieces of the two piece enclosures together. After the enclosures were sealed with the papers inside, the enclosures were submerged under approximately 10 cm of water. An image of the submerged enclosures is shown in Figure 4 (b). The cylindrical two piece design (Design 2) was removed from the water after 1 hour of submersion and the exterior was dried. The enclosure was then opened with a scalpel to remove the paper. The paper when removed from the enclosure showed no signs of moisture which indicated that the device cavity remained watertight over the period of submersion.
The rectangular enclosure (Design 1) was removed from the water after 5 hours of submersion and the exterior was dried. The enclosure was opened with a scalpel and the paper removed. The paper in this enclosure also showed no signs of moisture which indicates that the device cavity remained watertight over the 5 hours of submersion. 
Operation test
The operation test was performed with the single piece enclosure to evaluate if an active DBS device could be entirely submerged and remain operational. The DBS device was placed into the enclosure and the opening was sealed with medical-grade silicone (see Figure 5a ). A coin cell battery was then connected to the power wires and the device was activated. The output was connected across a 1 kΩ resistor in order to simulate brain tissue, and the output pulses were observed with an oscilloscope. The device and enclosure were then submerged in water and the operation of the device was similarly tested. As can be seen in Figure 5 (b), the device was still active and producing DBS signal pulses while completely submerged. 
Pressure testing
In order to gather some quantitative data on the performance of the enclosures a pressure test was performed, to measure the structural integrity of each of the enclosure prototypes. The enclosures were filled with 0.1cc of red dye to allow for easy identification of a leak or rupture in the enclosure, they were then sealed with medical grade silicone rubber. The enclosures were then cured for 24 hours at room temperature (approximately 21°C). Each enclosure was then placed individually in a vacuum desiccator (Thermo Scientific) in 30mm of water. A vacuum pump was used to evacuate the desiccator to a preset vacuum, this experimental setup can be seen in Figure 6 . A positive pressure variation is created between the test piece and the chamber and by measuring the pressure reading at which each enclosure leaks and ruptures their structural integrity can be quantifiably compared. The vacuum was increased from 0 kPa to 85 kPa in 5 kPa steps, stopping for 5 minutes at each step. The pressure at which each enclosure began to leak was recorded, as was the pressure at which the entire structural integrity failed and the enclosure expelled all of the dye as seen in Figure 7 . The experiment was performed three times on each enclosure design. The results from this experiment are shown in Figure 8 . Each of the enclosures began to leak at a pressure lower than 10 kPa and they all ruptured at under 55 kPa. A key observation made during this experiment, was that all of the enclosures leaked between the printed layers before fully rupturing.
Final design

Design
In response to the results obtained from the evaluation of the three prototype designs, a fourth and final design was developed. This final design aims to achieve a greater level of performance as the prototype designs in a more refined package. The final design was loosely based on the third prototype design and is shown in Figure 9 . The final design is a 14 mm tall rectangular design with base dimensions 4 mm × 7.8 mm. The inner cavity in this design is 13 mm × 2 mm × 5.8 mm. This is a significant improvement over the prototype design as extensive testing increased the achievable fabrication precision and allowed for a design with thinner walls. This design uses 26.4% less material than the third prototype design. This significant reduction in enclosure size is designed to minimise the impact that the implant has on the animal. 
Fabrication
This design was printed in silicone using the same process as the prototype enclosures. However, the parameters for this material in the bioprinter were changed due to extensive exploration into enhancing the print quality that occurred between the prints. These altered settings are outlined below in Table 2 .
Using a 200 µm tip instead of a 250 µm tip means that the print is of higher resolution than that in the prototypes and thinner enclosure walls can be produced without reduction in strength or significantly increasing the fabrication time. These settings allowed for the design to be produced rapidly (under 10 minutes per print) while still allowing for a high level of layer bonding. An image of the produced enclosure is shown in Figure 10 . Table 2 Improved bioplotter parameter settings for final design
Parameter Value
Plastic 
Testing
Submersion test
In order to assess the suitability of this enclosure, a long term temperature controlled submersion test was developed. This test aims to determine if a DBS device can be successfully isolated from an environment similar to that it would experience if it was to be implanted in an animal. The device was placed into the enclosure and the opening was sealed using medical grade silicone. In order to increase the similarity of this test to the environment found in the animal models, the device was submerged while operational within a glass beaker containing 500 ml of water. This beaker was placed upon a scientific digital hotplate and the temperature was increased to 37ºC, in order to mimic the environment found in the animal, this can been seen in Figure 11 . The device and enclosure were submerged in this apparatus for 24 hours to determine if the device remained operational after an extended period of time in this environment. An image of the device after being submerged for 18 hours is shown in Figure 12 .
After 24 hours of submersion the picture in Figure 13 was taken. As can be seen from the figure, the DBS device is still fully operational with a clear stimulation pulse being shown on the oscilloscope. This indicates that the device was isolated from the surrounding environment during the entire time it was submerged and that the 3D printed enclosure operated as designed. 
Pressure test
In order to compare the structural integrity of this final enclosure design against the three prototypes it was subjected to the pressure test as described in Section 3.3.3. The result of this enclosure design when compared to the others is shown in Figure 14 . The enclosures created using Design 3 reached the maximum possible pressure of 85 kPa without leaking or rupturing. One of the enclosures was left at this pressure for 48 hours, and still no sign of leak or rupture were detected.
Discussion and future work
From the findings gathered from this research it is clear that there is potential in using 3D printing to produce enclosures for implanted medical microdevices. All of the enclosures created as part of this research were fabricated from biocompatible materials and were able to successfully isolate the interior chamber from the exterior environment. When subjected to a quantitative pressure test it was clear that the final enclosure design which was fabricated at much higher resolution with thinner layers had the highest structural integrity. Through the use of rapid prototyping technologies, it was possible to design and produce these enclosures in a matter of hours rather than the 2+ week timeframe that it would take to get custom injection moulded enclosures produced (Bak, 2003) . This production time reduction would be of significant benefit in a number of settings, including in a pre-clinical study setting where build quantities are small and it is likely that there will be several design iterations completed in response to evaluation results.
Using 3D printing technology, medical device enclosures can be created earlier in the development process allowing for prototyping and evaluation of the final device to be performed prior to final production.
In addition to these advantages, the cost of producing enclosures in this manner is very low when compared to creating injection moulded enclosures with each print using low cost material and low cost consumables including standard 30 cc syringes and Luer lock syringe tips.
As a result of performing this research, a number of areas of future work and investigation have been identified. For instance, by altering the printing process, it may be possible to embed the DBS device directly into the enclosure at the time of printing. This would allow the enclosure to be fabricated and sealed in a single process, removing the need for additional silicone to seal the enclosure. There is also significant scope for future work in altering the characteristics of the printed silicone to allow it to interact directly with the device, instead of just functioning as an insulating layer.
Also, through modern rapid prototyping technologies such as selective laser melting, it is possible to produce medical device enclosures from a biocompatible metal such as titanium. These machines can produce highly complex objects by melting fine metal powders into the desired shapes. An enclosure for a DBS device created from this material would be extremely durable and resistant to corrosion while still maintaining a high level of biocompatibility (Vandenbroucke and Kruth, 2007) . Using a rapid prototyping system which is capable of working in metal such as the SLM ® 125HL as shown in Figure 15 (a), it should be possible to develop an enclosure entirely from titanium taking advantage of the highly desirable properties of this material whilst still allowing rapid low cost prototyping and development. Another area that has been identified as a potential area of further investigation is the fabrication of enclosures from biocompatible polymers such as Poly Methyl Methacrylate (PMMA). Using this material instead of silicone would add rigidity to the enclosures without decreasing the biocompatibility. Enclosures made from these materials could be fabricated on a 3D printer such as the Stratasys Connex3 Object 500 as shown in Figure 15 (b). This printer can produce objects from biocompatible polymers with a resolution of just 16 microns, allowing for extremely accurate fabrication of enclosures. Using this printer an investigation could also be carried out into the integration of highly complex exterior profiles to the enclosures and their effect on implantation. In addition, this printer can be used to produce a positive mould where Silicone can be injected into the mould to repeatedly produce enclosures for massvolume enclosure production.
Conclusion
The paper presented an approach for design and low-cost/rapid fabrication of biocompatible silicone enclosures for an implantable DBS microdevice. Design and creation of a number of 3D models was performed using a CAD software tool. Then, 3D printing of a number of prototype enclosures was performed using a bioprinter. An evaluation of the suitability of the enclosures for implantation of the DBS microdevice was completed through three tests and these results were used to develop a final design. The final design was designed, printed and then tested in a long term temperature controlled submersion test as well as a quantitative pressure test. The results of this tests demonstrated that there is significant potential in using this method for producing implantable enclosures to house medical microdevices. Through performing this research a number of areas of future work were identified.
